Usually, nasopharyngeal cancer bone metastasis can survive with tumor for a long time, and it is mainly treated with palliative therapy, including chemotherapy and radiotherapy. Nasopharyngeal cancer is a kind of malignant tumor originated from mucosal epithelium of nasopharynx. Bone metastasis of nasopharyngeal carcinoma is considered to have developed to the advanced stage of the disease. Since the treatment measures in this stage mainly adopt palliative treatment, and the first-line treatment guideline recommends chemotherapy combined with local radiotherapy, bone metastasis of nasopharyngeal carcinoma can survive with tumor for a long period of time. Clinical chemotherapeutic drugs for treating nasopharyngeal cancer bone metastasis include cisplatin, docetaxel, gemcitabine, etc. For patients in this stage, local radiotherapy is often adopted, which to a certain extent can effectively kill cancer cells and make them shrink, and at the same time, can relieve the symptoms of bone pain and so on, but it can not be a complete cure. To summarize, patients with nasopharyngeal cancer bone metastasis need to go to hospital for review on time, so that doctors can understand the changes of the disease. At the same time, they need to actively cooperate with doctors to carry out standardized treatment and strengthen daily life management. Generally, patients in middle and late stages can have better curative effect after appropriate comprehensive treatment.